Elanco Animal Health (ELAN) Operating Income Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) Operating Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 21.25% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 350.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.25% |
| Dec 31, 2025 | 92.03% |
| Sep 30, 2025 | 111.94% |
| Jun 30, 2025 | 141.75% |
| Mar 31, 2025 | 147.71% |
| Dec 31, 2024 | 14.15% |
| Sep 30, 2024 | 104.23% |
| Jun 30, 2024 | -2.73% |
| Mar 31, 2024 | -30.31% |
| Dec 31, 2023 | -19.74% |
| Sep 30, 2023 | -206.98% |
| Jun 30, 2023 | -3.01% |
| Mar 31, 2023 | 11.06% |
| Dec 31, 2022 | 15.43% |
| Sep 30, 2022 | 18.35% |
| Jun 30, 2022 | 36.80% |
| Mar 31, 2022 | 32.71% |
| Dec 31, 2021 | 30.71% |
| Sep 30, 2021 | 2.92% |
| Jun 30, 2021 | -111.26% |